Better Diabetes Control, Quality - Educate to Achieve Compliance. (MINERVA)

AstraZeneca

Status: Completed

Conditions: Diabetes Type 2

Study type: Observational

Funder types: Industry

Identifiers

NCT01728714

NIS-CPO-XXX-2012/1

CV/No drug/NIS-CPO-XXX-2012/1 (Other Identifier)

Details and patient eligibility

About

Prospective study to evaluate the impact of an educational programme about diabetes, comparing to normal clinical practice, on treatment compliance and disease control of people with type 2 diabetes followed in the primary care units in Portugal

Full description

Prospective study to evaluate the impact of an educational programme about diabetes focusing on treatment compliance, exercise and nutrition, comparing to normal clinical practice, on treatment compliance and disease control of people with type 2 diabetes followed in the primary care units in Portugal.

Enrollment: 227 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Individuals with type 2 diabetes
• HbA1c <= 8,5%
• Treated with oral antidiabetics for at least 6 months

Exclusion criteria

• Treatment with insulin

Trial design

227 participants in 2 patient groups

Adults over 18 years old

Description:

Adults over 18 years old, with type 2 diabetes, HbA1c \<= 8,5%, treated with oral antidiabetics at least for 6 months submitted to an educational programme during 1 year

Adults with HbA1c <= 8,5%

Description:

Adults over 18 years old, with type 2 diabetes, HbA1c \<= 8,5%, treated with oral antidiabetics at least for 6 months followed according to normal clinical practice during 1 year